ConductScience.org, home

Paper1320366

In vitro activities of five quinolones against Chlamydia pneumoniae.

Hammerschlag MR and 2 others. Antimicrob Agents Chemother, 1992. Cited by 54 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vitro activities of five quinolones against Chlamydia pneumoniae. Papers, record 1320366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1320366

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro activities of five quinolones against Chlamydia pneumoniae.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1992
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
2.78
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hammerschlag MRM R
2Hyman CLC L
3Roblin PMP M

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
Chlamydophila pneumoniaeMajor topic
CiprofloxacinMajor topic
FleroxacinMajor topic
FluoroquinolonesMajor topic
OfloxacinMajor topic
QuinolonesMajor topic
Microbial Sensitivity Tests

Source PubMed

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,571,425Persistent infection with Chlamydia pneumoniae following acute respiratory illness.Clin Infect Dis1992https://conductscience.org/library/papers/1571425PubMed
22,010,629Infection with Chlamydia pneumoniae in Brooklyn.J Infect Dis1991https://conductscience.org/library/papers/2010629PubMed
32,118,330In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2118330PubMed
43,058,015Susceptibility testing of Chlamydia trachomatis: from eggs to monoclonal antibodies.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3058015PubMed
52,252,040Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections.Am J Med1990https://conductscience.org/library/papers/2252040PubMed
62,672,243Tissue penetration of the new quinolones in humans.Rev Infect Dis1989https://conductscience.org/library/papers/2672243PubMed
72,817,862In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2817862PubMed
82,181,028A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.J Infect Dis1990https://conductscience.org/library/papers/2181028PubMed

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
19,332,673Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19332673PubMed
17,122,017Isolation and antimicrobial susceptibilities of Chlamydial isolates from Western barred bandicoots.J Clin Microbiol2007https://conductscience.org/library/papers/17122017PubMed
11,796,366In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/11796366PubMed
11,600,398In vitro and in vivo activities of sitafloxacin against Chlamydia spp.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11600398PubMed
10,553,711Activity of quinolones against Chlamydia pneumoniae.Drugs1999https://conductscience.org/library/papers/10553711PubMed
10,471,577In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10471577PubMed
9,559,818In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9559818PubMed
9,303,410In vitro activity of trovafloxacin against Chlamydia pneumoniae.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9303410PubMed
9,174,194In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9174194PubMed
9,087,506In vitro and in vivo antichlamydial activities of HSR-903, a new fluoroquinolone antibiotic.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9087506PubMed
8,913,488In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8913488PubMed
8,851,610Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8851610PubMed
8,665,464Chlamydia pneumoniae (TWAR).Clin Microbiol Rev1995https://conductscience.org/library/papers/8665464PubMed
8,540,698Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/8540698PubMed
8,494,377In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8494377PubMed
8,092,845In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8092845PubMed
7,986,006Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7986006PubMed
7,810,992Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7810992PubMed
7,689,439The future of the quinolones.Drugs1993https://conductscience.org/library/papers/7689439PubMed
7,601,015Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.Drugs1995https://conductscience.org/library/papers/7601015PubMed

See all 23 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1320366

GET https://conductscience.org/api/papers/v1/1320366/cited_by?page=2